This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Infectious Diseases Society of America says there's no evidence it conspired with insurers on Lyme-disease guidelines

( February 3, 2021, 22:31 GMT | Official Statement) -- MLex Summary: The Infectious Diseases Society of America and its members filed a motion for summary judgment against claims that they conspired to use arbitrary testing protocols to deny coverage for Lyme-disease treatments. “Because plaintiffs cannot produce admissible or probative evidence of payments from the insurance defendants to IDSA and all of the doctors to support their […] antitrust claims, summary judgment should be entered in favor of defendants dismissing those claims,” they said.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections